USPTO Director's First Patent Approvals Signal Support for Applied Technologies
New USPTO Director John A. Squires' initial patent approvals in blockchain and medical diagnostics indicate a pro-innovation stance that could accelerate commercialization timelines and strengthen investor confidence in technology sectors.
The Patent Baron PLLC has welcomed the early actions of newly sworn-in U.S. Patent and Trademark Office Director John A. Squires, who signed his first patents on his initial full day in office. The approvals included one in distributed-ledger/crypto technologies and another in medical diagnostics, signaling what the firm characterizes as a pro-innovation posture toward applied, real-world technologies that frequently face patent eligibility questions.
J. Baron Lesperance, founder of The Patent Baron PLLC, stated that for clients working in AI, blockchain/fintech, diagnostics, advanced manufacturing, and related fields, these actions represent a clear indication to proceed with patent filings. The firm interprets Director Squires' opening-day actions as both symbolic and practical, suggesting the Office intends to support patent-eligible, applied technologies while advancing workflow modernization and speed.
The ceremony also emphasized historic patent foundations and the enduring principle that applied technologies can qualify for patent protection. This aligns with the USPTO's 2025 modernization initiatives aimed at accelerating the period from Issue Notification to Issue Date, thereby improving commercialization timelines and investor certainty. Recent operational changes at the USPTO now target approximately a two-week window from Issue Notification to Issue Date, reducing time to market for innovators.
For innovators and companies, the implications include clearer eligibility guidance for applied technologies across sectors such as fintech, diagnostics, quantum computing, and artificial intelligence. Early actions by the Director, combined with pendency improvements, may de-risk funding discussions for IP-intensive startups and corporate research and development efforts. The firm is developing tailored strategies for founders and corporate teams to evaluate patent-eligibility, accelerate protection through mechanisms like Track One and prioritized examination, and strengthen portfolios via claim-drafting aligned with current USPTO guidance.
Lesperance emphasized that the firm's approach involves sharpened eligibility strategy, faster execution, and clearer value propositions for investors and acquirers. The dual patent issuances underscore the Office's focus on practical applications in technology sectors that have historically encountered eligibility challenges, potentially creating a more favorable environment for innovation commercialization. This development comes as the USPTO continues its modernization efforts at https://www.uspto.gov, which includes initiatives to streamline patent processes and support technological advancement.